HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Giordano Tasca Gilles Dreyfus George Asimakopoulos Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shaikhrezai, K. Articles by Asimakopoulos, G. Search for Related Content PubMed PubMed Citation Articles by Shaikhrezai, K. Articles by Asimakopoulos, G. Related Collections Valve disease Related Article

---

Original Articles: Adult Cardiac

Third-Time Aortic Valve Replacement: Patient Characteristics and Operative Outcome

Department of Cardiac Surgery, Harefield Hospital, Royal Brompton and Harefield NHS Trust, London, United Kingdom

Accepted for publication April 14, 2009.

^_* Address correspondence to Dr Asimakopoulos, Level 4, Dolphin House, Bristol Royal Infirmary, Bristol, BS2 8HW, United Kingdom (Email: george.asimakopoulos{at}uhbristol.nhs.uk).

Background: Reoperative cardiac surgery is being performed with increasing frequency. Third-time aortic valve surgery remains a rare procedure. We retrospectively analyzed the outcome of third-time aortic valve replacement (AVR) at our institution.

Methods: Between 1990 and 2005, 49 patients underwent third-time AVR. Data analyzed included preoperative patient characteristics, type of preexisting aortic valve prosthesis, prosthetic valve pathology necessitating third-time AVR, postoperative morbidity and mortality, and echocardiographic data.

Results: The mean age was 47.4 ± 17 years. The mean interval between the first and second operation was 8.7 ± 5.7 years, and between the second and third operation it was 10.2 ± 5.6 years. Prosthetic valves at the time of second AVR included 32 homografts (65.4%), 11 mechanical prostheses (22.4%), and 6 xenografts (12.2%). At third-time AVR, 29 patients (59.2%) received a homograft or autograft, 12 (24.5%) received a mechanical valve, and 8 (16.3%) received a xenograft. In-hospital mortality was 4.1%. The mean follow-up was 80 ± 69 months. Freedom from reoperation was 84% ± 6% at 5 years and 65% ± 11% at 10 years. Long-term survival was 79% ± 6% at 5 years and 73% ± 7% at 10 years. Multivariate analysis showed that age, female sex, and postoperative high left ventricular mass were factors associated with decreased long-term survival. Mean left ventricular mass decreased from 320 ± 133 g to 263 ± 102 g at 1 year postoperatively (p = 0.01).

Conclusions: Third-time AVR can be performed with low operative mortality, low cumulative operative mortality, and satisfactory long-term survival and freedom from reoperation. The procedure results in significant regression of left ventricular mass.

Related Article

Invited Commentary

Tomislav Mihaljevic
Ann. Thorac. Surg. 2010 89: 484. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				P. G. Malvindi, B. P. van Putte, A. Leone, R. H. Heijmen, M. A. A. M. Schepens, and W. J. Morshuis Aortic Reoperation After Freestanding Homograft and Pulmonary Autograft Root Replacement Ann. Thorac. Surg., April 1, 2011; 91(4): 1135 - 1140. [Abstract] [Full Text] [PDF]

				T. Mihaljevic Invited Commentary Ann. Thorac. Surg., February 1, 2010; 89(2): 484 - 484. [Full Text] [PDF]